Citi Pharma Limited (PSX:CPHL)

Citi Pharma Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	17,875	6,511	4,875	7,457	-	-
Market Cap Growth	186.90%	33.55%	-34.62%	-	-	-
Enterprise Value	18,493	6,236	4,443	5,627	-	-
Last Close Price	78.24	26.42	17.82	27.26	-	-
PE Ratio	21.74	7.81	7.41	11.41	-	-
PS Ratio	1.35	0.53	0.39	0.76	-	-
PB Ratio	3.34	1.16	0.91	1.58	-	-
P/TBV Ratio	3.34	1.16	0.91	1.58	-	-
P/FCF Ratio	190.51	8.46	-	-	-	-
P/OCF Ratio	34.41	4.87	-	-	-	-
EV/Sales Ratio	1.40	0.50	0.36	0.57	-	-
EV/EBITDA Ratio	12.90	4.65	3.53	5.28	-	-
EV/EBIT Ratio	14.42	5.17	3.81	5.66	-	-
EV/FCF Ratio	197.10	8.11	-	-	-	-
Debt / Equity Ratio	0.34	0.26	0.34	0.20	0.07	0.49
Debt / EBITDA Ratio	1.25	1.08	1.46	0.88	0.50	1.57
Debt / FCF Ratio	19.17	1.89	-	-	-	-
Asset Turnover	-	1.16	1.37	1.34	1.29	1.86
Inventory Turnover	-	3.72	5.06	6.82	6.02	6.24
Quick Ratio	0.59	0.68	0.80	1.15	1.92	0.31
Current Ratio	1.24	1.36	1.48	1.86	2.45	1.11
Return on Equity (ROE)	-	15.14%	13.05%	14.40%	13.16%	15.79%
Return on Assets (ROA)	-	7.05%	8.06%	8.49%	7.96%	8.38%
Return on Capital (ROIC)	-	10.54%	11.34%	12.01%	11.62%	12.00%
Return on Capital Employed (ROCE)	23.00%	20.60%	21.10%	19.40%	12.20%	20.80%
Earnings Yield	4.60%	12.80%	13.50%	8.77%	-	-
FCF Yield	0.52%	11.82%	-26.33%	-12.38%	-	-
Dividend Yield	4.57%	12.30%	14.03%	-	-	-
Payout Ratio	90.37%	68.53%	-	47.66%	-	-
Buyback Yield / Dilution	-0.01%	-	-0.70%	-21.65%	-88.38%	-
Total Shareholder Return	4.56%	12.30%	13.32%	-21.65%	-88.38%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.